Summary We analysed chromosome 3p for loss of heterozygosity (LOH) 
When cancer is first diagnosed, treatment for an individual is based on an estimation of the expected behaviour of the tumour and the patients prognosis, with aggressive disease requiring more aggressive treatment. At present, prognostic information for oral cancer is obtained after taking into account the clinical stage of the tumour and after microscopical examination of tissue obtained following biopsy. However, tumours that appear similar morphologically and histologically will show varying responses when treated in identical ways.
The results of treatment for oral cancer have remained at a disappointingly stable level for many years. Current treatment protocols may not offer the best chance of longterm survival (Henk and Langdon, 1994) . Many patients develop local or nodal recurrence within 2 years (Hirata et al., 1975) and may develop a second primary tumour in the upper aerodigestive tract (Carr and Langdon, 1989) . Although surgical techniques have developed in recent years and local control of this disease has improved, more patients are developing metastatic disease within 5 years (Luna, 1983) and the chances of long palliation with radiotherapy or chemotherapy are slight. In order to improve management of oral cancer patients we need to develop a better understanding of the biological diversity that exists within lesions that appear similar morphologically, to identify their potential for progression accurately and to use this information to modify existing treatment regimens to improve clinical course and outcome.
Chromosomal deletions at 3p have been reported for tumours of the lung, kidney, breast, uterine cervix, endometrium, ovary, testes, head and neck and oral cavity (reviewed by Jones and Nakamura, 1992) (Wright and Manos, 1990 (Table II) . The percentage of informative cases with loss at each locus varied between 0% and 37%, (Table I) . When all loci were considered the overall LOH for 3p was 34/48 (71%). In this study the frequency of LOH for loci at 3q was 4-10%. This is lower than the incidence of 10-15% random loss reported for other studies of head and neck SCC (Ah-See et al., 1994; Narwoz et al., 1994; Naylor et al., 1994) and may reflect the high percentage of early stage 1 and 2 tumours examined. The frequency of LOH at D3S1307, D3S647 and D3S1076 was below the threshold for random loss at 3q and these loci were considered to lie outside of the regions which may contain suppressor genes.
Examination of the pattern of LOH reveals interstitial losses at three regions at this chromosome arm. Allelic deletion at a single region occurred in 19/48 (40%) cases, 15/ 48 (31%) showed deletion of two or three regions and 14 cases retained heterozygosity at all informative loci. The likely map positions of the markers (Figure la ) and the extent of single and multiple deletions is summarised diagrammatically (Figure lb) . The map position of some of the markers used has not been precisely defined and in this schematic representation the order of the markers is shown after taking into account the likely map positions together with the pattern of allelic deletions in the tumours examined. When alleles were lost in the tumour, loss was not always complete owing to contamination of the sample with normal cells. A series of representative cases is shown (Figure 2 When analysing the results we considered the number of regions showing LOH at 3p rather than the number of deleted loci (as several tumours show loss of adjacent loci within a commonly deleted region). Study of potentially malignant lesions also reveals that deletion at several adjacent loci occur in premalignant lesions (Emilion et al., 1995) . There was a significant correlation between the number of deleted regions at 3p and presence of positive lymph nodes at histological examination (U= 137, P=0.004) and tumour stage (r,=0.586, P<0.001, Figure 3 ).
We also compared the presence or absence of LOH at any of the loci examined at 3p (as LOH + /LOH -) to analyse the results in relation to other clinicopathological parameters and known risk factors for oral cancer. LOH + /LOH -at 3p was compared among the three histological groups well-, moderately and poorly differentiated but no correlation was found (chi-square 4.10, P0.12) and there was no relation between smoking habits and LOH at 3p (Chi-square 3.87, P0.14) or alcohol consumption (chi-square 1.2, P0.55, moderate and heavy drinkers were combined for statistical analysis).
We calculated the overall survival time from the date of tumour diagnosis. Analysis of this survival data showed that LOH at 3p is associated with a significant reduction in mean survival time and is a marker of poor prognosis (log-rank 5.13, P0.023, Figure 4a ). Only three advanced stage 3 or 4 tumours show no LOH at 3p. Separation of the cases into early (stage 1 and 2) and advanced stage tumours identifies a subgroup of patients with aggressive early disease associated with reduced overall survival, (log-rank 5.32, P0.021, Figure  4b ). LOH at 3p also reduces the disease-free survival time Examples of LOH at D3S192 (case 2), D3S32 (case 8), THRB and D3S30 (case 26). All cases retain heterozygosity at the other loci shown. Markers were amplified from DNA derived from blood (N) and tumour (T). The numbering of the patients is the same as used in Table I . +-, alleles detected by microsatellite assay. Al and A2 represent the polymorphic alleles detected by RFLP analysis. The signal from the smaller second allele is not readily detected in some cases.
(log-rank 4.08, P 0.043, Figure 4c) . Although these results demonstrate that LOH at 3p correlates with reduced survival, the number of cases examined is insufficient to permit multivariate analysis to see whether this association would remain significant when other known prognostic markers are taken into account.
Discussion
Our previous studies of LOH at 3p for primary oral SCCs showed allele loss in 81% of informative cases (Partridge et al., 1994). A subsequent study has shown loss in 52% of Jones and Nakamura, 1992; Hibi et al., 1993; Kohono et al., 1993; Maestro et al., 1993; Chen et al., 1994; Wu et al., 1994) and (Yokota et al., 1989 Hibi et al., 1993 Kohono et al., 1993; Maestro et al., 1993; Chen et al., 1994; Partridge et al., 1994) . The most commonly deleted region in this study was between 3p24-pter, a finding recently reported for head and neck cancer (Li et al., 1994) . The second most frequently deleted region was at 3p2l.3-22.1. Earlier studies have also indicated that an area at 3p2l-23 is frequently deleted in head and neck and oral cancer (Maestro et al., 1993; Wu et al., 1994 (Hibi et al., 1993) it has been suggested that the common regions of deletion at 3p may be a reflection of the contribution of tobacco to the pathogenesis of these lesions. However this study failed to demonstrate an association with = 14) tobacco consumption, (or high alcohol intake, another risk factor for oral cancer) and allele loss at 3p. The significant correlation between the number of deleted regions at 3p and tumour stage is consistent with the concept that the progressive accumulation of genetic events is associated with advanced disease (Fearon and Vogelstein, 1990 
